Stanford MS Biomedical Data Science

What is the Stanford MS Biomedical Data Science?

The Stanford MS Biomedical Data Science is a 45-unit, full-time campus degree planned across about 21 months. Its official curriculum provides the programme-specific scope used for this decision. The conservative full-programme plan is INR 2.29 crore, using 2026-27 tuition and Stanford’s current graduate living budget.

For Autumn 2027, the academic path begins with Biomedical Data Science and Introduction to Biomedical Informatics Research Methodology, then moves into Data-Driven Medicine and Computational Methods for Biomedical Data. Applications follow the programme’s published 2027 timetable; Stanford has not yet published 2027-28 tuition, so this page retains the latest 2026-27 rates and labels the estimate.

The sequence from Biomedical Data Science through Introduction to Biomedical Informatics Research Methodology establishes biostatistics and machine learning. Data-Driven Medicine then tests bioinformatics, while Computational Methods for Biomedical Data gives the applicant a route into clinical data analysis. That progression, not Stanford’s name alone, is the academic reason to choose this programme.

A comparison with a neighbouring degree should begin at Biomedical Data Science, not at the university label. In MS Biomedical Data Science, that component establishes biostatistics before Introduction to Biomedical Informatics Research Methodology develops machine learning. The sequence is useful for biomedical data scientist work only when the second component adds a capability that the applicant cannot already demonstrate.

The later curriculum changes the decision again. BIOMEDIN 215 links the programme to clinical data analyst evidence, while BIOMEDIN 260 serves the different problem of health AI researcher preparation. An applicant who needs neither route may be paying for breadth that does not advance the intended work.

How much does the Stanford MS Biomedical Data Science cost for an Indian student?

The full planning case is USD 238,548, about INR 2.29 crore. It combines the latest published or schedule-derived tuition and fees, Stanford’s graduate living categories for 21 months, the application fee, SEVIS and the F-1 visa fee, before flights and a housing deposit.

The table treats the SEVIS and visa charges as separate payments. It does not add a second visa-maintenance total because the complete living plan already covers the study period. Converted at USD 1 = INR 95.98, derived from ECB reference rates dated 28 September 2026.

Stanford requires international graduate students to submit a financial guarantee before the university can issue an I-20.Stanford international graduate admission

The living line starts from Stanford’s published annual graduate categories. Those figures include housing and meals, books and supplies, transport and personal costs. The 21-month multiplication is a planning assumption, so a shorter completion pattern or different housing choice changes the total.

The tuition line is a transparent calculation of 45 credits from the current school-specific 2026-27 tuition basis. It is not an invoice. Programme fees, term load and future board decisions can change what Stanford bills.

Flights, exchange spreads, a refundable housing deposit and personal contingency remain outside the table. They vary too much to attach one official amount to every applicant, but they still need cash in the funding plan before departure.

A scholarship should reduce the plan only after it appears in a written award. Campus employment is limited, competitive and dependent on authorisation, so it is not a sound way to close a known tuition gap at the application stage.

The estimate isn’t an invoice, doesn’t cap individual spending and can’t replace the payment terms in an Stanford offer. It won’t predict actual housing costs and shouldn’t be treated as a scholarship assumption. It is a common comparison case that keeps the main assumptions visible before an applicant commits.

The institution identity is independently recorded by the Research Organization Registry. That confirms the provider behind the bill, while the offer and student account remain the controlling sources for the amount and due dates.

Can an Indian candidate meet Stanford MS Biomedical Data Science entry rules?

The first check uses the school’s official admission route. It requires an accepted bachelor’s degree or an international equivalent, with calculus, probability, statistics, programming and biology and does not publish a numeric minimum GPA for this programme. Subject preparation, English evidence and every listed document remain separate checks.

The 2027 testing position for MS Biomedical Data Science is explicit: GRE General and Subject tests not considered. That rule belongs to this programme and cycle; a different Stanford department can use a different policy.

Readiness for MS Biomedical Data Science can be mapped to the curriculum. Prior work should make biostatistics visible before Biomedical Data Science, show a base for machine learning before Introduction to Biomedical Informatics Research Methodology, and explain why graduate depth in bioinformatics is still needed.

For Biomedical Data Science, the admissions file should name prior work in biostatistics and preserve enough detail to show its level. A transcript title alone can hide whether the applicant solved, built or evaluated anything relevant to biomedical data scientist preparation.

Readiness for Introduction to Biomedical Informatics Research Methodology is a separate judgement. Evidence in machine learning should identify the input, method and result, then explain what remained unresolved. That shows whether graduate work is the next step without claiming that professional experience substitutes for academic preparation.

The sharpest subject test sits between BIOMEDIN 215 and BIOMEDIN 260. Someone prepared for bioinformatics but not clinical data analysis should verify that the approved plan leaves enough room to repair the second gap. Stanford’s flexible electives do not erase prerequisites for an advanced class.

A useful statement for MS Biomedical Data Science therefore connects BIOMEDIN 205 to BIOMEDIN 215, then explains why the culminating work is necessary for the intended clinical data analyst direction. Repeating Stanford’s description would not prove that progression.

BIOMEDIN 205 positions biostatistics as preparation for biomedical data scientist work. Before BIOMEDIN 205, the file should show biostatistics in a completed problem, not only in a module name. That earlier biostatistics result needs enough method detail for a biomedical data scientist reviewer to judge its level. An unresolved biostatistics limitation is a credible reason to choose BIOMEDIN 205. A mature biostatistics portfolio instead makes machine learning the more useful comparison. Missing biostatistics foundations would make the pace of BIOMEDIN 205 a risk rather than a remedy. A recommendation for biomedical data scientist preparation can identify where the applicant’s biostatistics reasoning stops. The statement can then explain which BIOMEDIN 205 method should extend that reasoning. Evidence for biomedical data scientist readiness should keep the assumptions behind the prior biostatistics result. If those assumptions are absent, BIOMEDIN 205 cannot be justified by a polished output alone. The alternative machine learning route should be costed whenever it better matches the unresolved problem. That biostatistics versus machine learning decision is more useful than a general claim about Stanford. For biomedical data scientist goals, BIOMEDIN 205 therefore needs a named input, method and expected improvement. The admission case becomes weaker when biostatistics is asserted but never demonstrated. It becomes coherent when BIOMEDIN 205, biostatistics and the biomedical data scientist objective form one sequence. Preparation for Biomedical Data Science can be checked against the applicant’s record in calculus, linear algebra, probability, statistics, programming and biological science. The admission value of Biomedical Data Science lies in showing why biostatistics needs graduate extension for machine learning, statistics and computation for biomedical evidence. A credible starting point for Biomedical Data Science should also connect the earlier biostatistics result to the later machine learning requirement. That chain makes Biomedical Data Science a preparation claim for biomedical data scientist, not a general statement of interest.

Three checks that can block a MS Biomedical Data Science application

1. No published GPA number is not an admission promise

   Stanford does not state a numeric minimum for this programme. That does not make academic performance irrelevant; the school can still compare grades, subject depth and the strength of the complete application.

2. The degree title cannot prove prerequisites

   A broad Indian degree title may hide whether biostatistics and machine learning were studied at the expected depth. Syllabi or official course descriptions can make that preparation visible when transcript titles do not.

3. English rules can be Stanford course-specific

   The working reference is TOEFL 4.5 or IELTS 7 unless an exemption applies. Stanford says individual programmes may set higher rules or restrict test formats, so the exact degree page controls.

How should an Indian applicant apply for Stanford MS Biomedical Data Science?

The application follows the official School of Medicine route for the exact campus programme. The current Autumn 2027 status is 1 December 2026 for Autumn 2027. The planning timeline allows 75 days after an offer for funding evidence, I-20 work, SEVIS payment and the visa process.

Select the exact in-person degree, upload the academic and programme documents, pay the international application fee, monitor My Stanford, clear every offer condition, submit the financial guarantee and then complete the I-20 and F-1 steps.

The allowances are Nbyula planning estimates, not processing times published by Stanford University.

Build the file around Biomedical Data Science and Introduction to Biomedical Informatics Research Methodology, not around a generic Stanford statement. Use earlier coursework or employment to show readiness, then identify the gap that the published curriculum is meant to close.

The official status is 1 December 2026 for Autumn 2027. A priority date and a final closure serve different purposes, and a published academic deadline is separate from the time needed for the I-20 and visa process.

After admission, read the offer and My Stanford task list line by line. Financial guarantee, final transcripts, immunisation records and I-20 processing can each continue after the academic decision and can each delay enrolment if ignored.

For F-1 planning, check the SEVIS I-901 step and the US visa fee page directly. Fee payment does not guarantee a visa, and a programme offer does not replace consular review.

What jobs can follow Stanford MS Biomedical Data Science?

The academic map supports directions such as biomedical data scientist, bioinformatics scientist, clinical data analyst and health AI researcher. Stanford marks the degree STEM-OPT eligible, but the OPT framework is work authorisation rather than a placement or sponsorship guarantee. Each direction still needs role-specific, inspectable work samples.

These are curriculum-linked directions for MS Biomedical Data Science, not a measured probability of employment, salary, sponsorship or promotion. Stanford publishes no exact-programme placement rate here unless a row states a named cohort and denominator.

A biomedical data scientist portfolio can draw most directly on BIOMEDIN 205, whereas bioinformatics scientist evidence is more likely to depend on BIOMEDIN 212. BIOMEDIN 215 may support a clinical data analyst direction and BIOMEDIN 260 a health AI researcher direction. These are evidence routes, not four promised jobs.

Work from Biomedical Data Science can support a biomedical data scientist application when it preserves the problem, assumptions, method and failed alternatives. The same output is weak evidence for bioinformatics scientist work unless Introduction to Biomedical Informatics Research Methodology adds the different machine learning judgement that role requires.

For clinical data analyst work, Data-Driven Medicine matters because it can turn bioinformatics into an inspectable result. The hiring value comes from explaining that result and its limitations, not from listing Data-Driven Medicine on a transcript.

The health AI researcher direction is more dependent on Computational Methods for Biomedical Data and clinical data analysis. If the candidate’s approved electives cannot deepen that pair, the course may still be academically strong but poorly aligned with the stated role.

None of these four directions changes the immigration test. OPT depends on the degree classification, timely authorisation and qualifying work, while any STEM extension also depends on the employer and reporting rules. MS Biomedical Data Science does not make sponsorship automatic.

BIOMEDIN 212 can translate machine learning into evidence for a bioinformatics scientist application. The strongest BIOMEDIN 212 artefact would record how a machine learning decision was made and revised. A bioinformatics scientist reviewer needs the failed alternative as well as the successful machine learning result. Without that reasoning, listing BIOMEDIN 212 proves attendance rather than machine learning capability. The candidate should separate individual machine learning contributions from any team output in BIOMEDIN 212. Constraints attached to the BIOMEDIN 212 task also matter because bioinformatics scientist work rarely begins with clean inputs. Where confidentiality limits the BIOMEDIN 212 submission, a public machine learning demonstration may be necessary. That extra demonstration should be planned while the bioinformatics scientist problem is still fresh. For a clinical data analyst direction, bioinformatics may produce more relevant evidence than BIOMEDIN 212. The bioinformatics scientist choice should therefore compare machine learning with bioinformatics, not collect both automatically. A useful BIOMEDIN 212 result explains uncertainty in language a bioinformatics scientist audience can test. It also shows how the applicant would transfer machine learning beyond the classroom task. Employer demand and work authorisation remain separate from the BIOMEDIN 212 assessment. Neither the course nor a strong machine learning artefact guarantees a bioinformatics scientist offer. Their value is a clearer, inspectable case for the chosen bioinformatics scientist direction. After Introduction to Biomedical Informatics Research Methodology, a useful portfolio should make one machine learning judgement inspectable to a bioinformatics scientist audience. The outcome case for Introduction to Biomedical Informatics Research Methodology is stronger when the programme’s culminating work gives that machine learning judgement a larger purpose. Earlier machine learning evidence can then be compared with the new Introduction to Biomedical Informatics Research Methodology method and its bioinformatics scientist use. This outcome reading separates the bioinformatics scientist use of Introduction to Biomedical Informatics Research Methodology from the different clinical data analyst path.

Who is Stanford MS Biomedical Data Science for, and who should avoid it?

A strong fit already has preparation in biostatistics and machine learning, wants assessed evidence in bioinformatics and can fund INR 2.29 crore without promised employment. A weak fit needs foundational repair, wants a different academic centre or depends on uncertain US earnings to make the course affordable.

The practical fit test is whether biostatistics and machine learning are foundations rather than missing prerequisites. Someone already able to show advanced results across bioinformatics and clinical data analysis should compare a narrower route before paying for overlap.

A strong MS Biomedical Data Science profile can already explain biostatistics through a real result, yet still needs Biomedical Data Science for graduate depth. A weak profile hopes the course will teach the undergraduate foundation from the beginning.

For a candidate moving towards bioinformatics scientist, Introduction to Biomedical Informatics Research Methodology should close a named gap in machine learning. If the applicant has already produced advanced work in that area, the better use of tuition may be a programme centred on bioinformatics or another specialism.

The clinical data analyst case depends on access to Data-Driven Medicine and a credible way to retain the assessed work. Where confidentiality removes every output, the candidate needs another route to demonstrate bioinformatics after graduation.

Someone targeting health AI researcher should read the rules around Computational Methods for Biomedical Data before accepting an offer. Course availability, prerequisites and timetable conflicts can matter more than a broad list of electives when clinical data analysis is the reason for enrolling.

Cost fit is independent of subject fit. Even an excellent match across BIOMEDIN 205, BIOMEDIN 212, BIOMEDIN 215 and BIOMEDIN 260 is a poor decision if the applicant needs a guaranteed scholarship, campus job or US salary to make the published full-programme budget viable.

Fit around BIOMEDIN 215 depends on the distance between current bioinformatics ability and a clinical data analyst target. A candidate new to bioinformatics should not assume BIOMEDIN 215 will rebuild every prerequisite at graduate pace. A candidate already advanced in bioinformatics needs BIOMEDIN 215 to add a distinct clinical data analyst method. The planned BIOMEDIN 215 output should expose data, constraints and uncertainty around that bioinformatics method. A redacted or reproducible version matters when clinical data analyst evidence cannot remain confidential. If BIOMEDIN 215 cannot yield inspectable bioinformatics work, the portfolio plan needs another route. The competing route is clinical data analysis, especially for applicants leaning toward health AI researcher. Units assigned to BIOMEDIN 215 are hard to defend when clinical data analysis closes the more important gap. The full cost makes this bioinformatics versus clinical data analysis trade-off material. Academic curiosity about BIOMEDIN 215 is not by itself a fit argument for clinical data analyst preparation. The fit argument must name the bioinformatics deficit and the standard used to judge improvement. It should also state why a narrower clinical data analyst route cannot resolve the same deficit. That comparison protects the plan from overlapping bioinformatics and clinical data analysis electives. For clinical data analyst ambitions, every BIOMEDIN 215 unit should support an identifiable capability test. Otherwise the candidate may prefer a programme built more directly around health AI researcher needs. For fit, Data-Driven Medicine should resolve a named weakness in bioinformatics rather than add undirected breadth for clinical data analyst goals. Applicants bringing existing bioinformatics work can ask whether Data-Driven Medicine deepens or merely repeats that preparation. The answer should be tested against the place of Data-Driven Medicine in the final programme requirement and the clinical data analyst portfolio. If that connection is thin, the health AI researcher option deserves more attention than the clinical data analyst route.

What does the Stanford MS Biomedical Data Science curriculum contain?

The official curriculum requires 45 credit hours. The table preserves every named coded item found on that page and keeps published curriculum areas where Stanford directs students to an approved list. Availability and prerequisites still need a live check before enrolment.

The note “Published curriculum item” applies to 4 components in this table.

• Complete 45 approved graduate credit hours.
• Follow the published choice among a biomedical data science research project and approved depth work.
• Confirm approved electives, prerequisites and the plan of study with the academic unit.

Use the required sequence to establish readiness for Biomedical Data Science, then choose electives that deepen bioinformatics instead of creating several disconnected introductions. The official plan of study remains the authority for what can count together.

Stanford can revise course availability and approved lists. Recheck every code, credit value, campus offering and culminating route before accepting an offer, especially where the catalogue publishes an area rather than a closed list of named electives.

Should an Indian candidate shortlist the Stanford MS Biomedical Data Science?

Shortlist the Stanford MS Biomedical Data Science when your transcript already supports biostatistics and machine learning, your intended work uses bioinformatics and the full INR 2.29 crore plan is fundable without depending on uncertain work income. Treat those as separate thresholds.

The strongest case connects Biomedical Data Science to Introduction to Biomedical Informatics Research Methodology, then uses the culminating route to create inspectable proof. That is a clearer reason to choose this Stanford course than a general wish to study at a large US university.

Stanford does not publish a numeric entry GPA floor for this programme, but selection can still test subject depth and overall academic strength. The conservative cost case is INR 2.29 crore before flights and a housing deposit, and Stanford publishes no guaranteed job or sponsorship outcome for this exact programme.

Sources

These sources support the programme, admission, cost, experience and immigration information used on this page.

Sources checked on September 29, 2026. Current intake information follows. Autumn 2027 full-time on-campus.